» Articles » PMID: 37063856

Deep Characterization of Human γδ T Cell Subsets Defines Shared and Lineage-specific Traits

Overview
Journal Front Immunol
Date 2023 Apr 17
PMID 37063856
Authors
Affiliations
Soon will be listed here.
Abstract

Under non-pathological conditions, human γδ T cells represent a small fraction of CD3 T cells in peripheral blood (1-10%). They constitute a unique subset of T lymphocytes that recognize stress ligands or non-peptide antigens through MHC-independent presentation. Major human γδ T cell subsets, Vδ1 and Vδ2, expand in response to microbial infection or malignancy, but possess distinct tissue localization, antigen recognition, and effector responses. We hypothesized that differences at the gene, phenotypic, and functional level would provide evidence that γδ T cell subpopulations belong to distinct lineages. Comparisons between each subset and the identification of the molecular determinants that underpin their differences has been hampered by experimental challenges in obtaining sufficient numbers of purified cells. By utilizing a stringent FACS-based isolation method, we compared highly purified human Vδ1 and Vδ2 cells in terms of phenotype, gene expression profile, and functional responses. We found distinct genetic and phenotypic signatures that define functional differences in γδ T cell populations. Differences in TCR components, repertoire, and responses to calcium-dependent pathways suggest that Vδ1 and Vδ2 T cells are different lineages. These findings will facilitate further investigation into the ligand specificity and unique role of Vδ1 and Vδ2 cells in early immune responses.

Citing Articles

T cell related osteoimmunology in fracture healing: Potential targets for augmenting bone regeneration.

Wang H, Li Y, Li H, Yan X, Jiang Z, Feng L J Orthop Translat. 2025; 51:82-93.

PMID: 39991456 PMC: 11847249. DOI: 10.1016/j.jot.2024.12.004.


The pancreatic tumor microenvironment of treatment-naïve patients causes a functional shift in γδ T cells, impairing their anti-tumoral defense.

Lo Presti E, Cupaioli F, Scimeca D, Unti E, Di Martino V, Daidone R Oncoimmunology. 2025; 14(1):2466301.

PMID: 39945298 PMC: 11834455. DOI: 10.1080/2162402X.2025.2466301.


Impact of perinatal factors on T cells and transcriptomic changes in preterm infant brain injury.

Zhang X, Yang Y, Xu Y, Chen L, Niu M, Zhu J J Neuroinflammation. 2024; 21(1):310.

PMID: 39614291 PMC: 11607874. DOI: 10.1186/s12974-024-03311-4.


Vδ2 T-cell engagers bivalent for Vδ2-TCR binding provide anti-tumor immunity and support robust Vγ9Vδ2 T-cell expansion.

King L, de Jong M, Veth M, Hulsik D, Yousefi P, Iglesias-Guimarais V Front Oncol. 2024; 14:1474007.

PMID: 39493452 PMC: 11527600. DOI: 10.3389/fonc.2024.1474007.


Dual role of circulating and mucosal Vδ1 T cells in the control of and contribution to persistent HIV-1 infection.

Mann B, Sanz M, Clohosey M, Langlands K, Chitrakar A, Moreno C Res Sq. 2024; .

PMID: 39149467 PMC: 11326412. DOI: 10.21203/rs.3.rs-4784403/v1.


References
1.
Kaminski H, Menard C, El Hayani B, Adjibabi A, Marseres G, Courant M . Characterization of a Unique γδ T-Cell Subset as a Specific Marker of Cytomegalovirus Infection Severity. J Infect Dis. 2020; 223(4):655-666. DOI: 10.1093/infdis/jiaa400. View

2.
Brenner M, McLean J, Dialynas D, Strominger J, Smith J, Owen F . Identification of a putative second T-cell receptor. Nature. 1986; 322(6075):145-9. DOI: 10.1038/322145a0. View

3.
Wu D, Wu P, Qiu F, Wei Q, Huang J . Human γδT-cell subsets and their involvement in tumor immunity. Cell Mol Immunol. 2016; 14(3):245-253. PMC: 5360884. DOI: 10.1038/cmi.2016.55. View

4.
Bukowski J, Morita C, Tanaka Y, Bloom B, Brenner M, Band H . V gamma 2V delta 2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer. J Immunol. 1995; 154(3):998-1006. View

5.
Jouen-Beades F, Paris E, Dieulois C, Lemeland J, Marret S, Humbert G . In vivo and in vitro activation and expansion of gammadelta T cells during Listeria monocytogenes infection in humans. Infect Immun. 1997; 65(10):4267-72. PMC: 175612. DOI: 10.1128/iai.65.10.4267-4272.1997. View